Newest
BETR ▼ sold $13K · Tuffin Paula filed 2d agoBETR ▼ sold $14K · Nicholas J. Calamari filed 2d agoFBK ▲ bought $716K · INGRAM ORRIN H II filed 2d agoFBK ▲ bought $821K · INGRAM ORRIN H II filed 2d agoBEN ▼ sold $5.0M · FRANKLIN TEMPLETON INC filed 2d agoNAD ▼ sold $338K · Robert Young L filed 3d agoWSBC ▼ sold $15K · Rep. Michael A. Rulli filed 4d agoGOOG ▼ sold $100K · Rep. Michael A. Rulli filed 4d agoWMT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoVSAT ▼ sold $100K · Rep. Jonathan L. Jackson filed 4d agoTYG ▼ sold $15K · Rep. Jonathan L. Jackson filed 4d agoGH ▲ bought $50K · Rep. Jonathan L. Jackson filed 4d agoEL ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoDDOG ▲ bought $100K · Rep. Jonathan L. Jackson filed 4d agoCPRT ▼ sold $553K · Morefield Diane M filed 4d agoPTON ▼ sold $154K · Kirol Charles Peter filed 4d agoEME ▲ bought $1K · MCEVOY M KEVIN filed 4d agoEME ▲ bought $826 · MCEVOY M KEVIN filed 4d ago

Stock / equity

ATTO Attovia Therapeutics, Inc.

Company
Attovia Therapeutics, Inc.
Security
Equity
Insiders on record
13
Latest trade on record
August 6, 2026

ATTO (Attovia Therapeutics, Inc.) has 90 disclosed insider transactions from 13 insiders in the last 12 months (9 open-market buys, 45 sales, about $56.9M at reported prices) and 0 congressional trades from 0 members of Congress. The most recent disclosure was filed August 13, 2026.

Last updated August 13, 2026 · Sources: SEC EDGAR Form 4; House Clerk and Senate eFD PTRs

Insider txns (12m)
90
Open-market buys / sales
9 / 45
Congress trades (12m)
0
Distinct filers (12m)
13

Share price

Price and chart by TradingView for Attovia Therapeutics, Inc.. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.

ATTO in charts

Who is trading this stock

Which people account for the buying and selling over the last 12 months?

BoughtSold
GOLDMAN SACHS GROUP INC$13MRedmile Group, LLC$10MFrazier Life Sciences XI, L…$10.0MvenBio Global Strategic Fun…$6.5MSanofi$5.1MWALSH COLIN$644K
GOLDMAN SACHS GRO…$13MRedmile Group, LLC$10MFrazier Life Scie…$10.0MvenBio Global Str…$6.5MSanofi$5.1MWALSH COLIN$644K

6 people account for the disclosed buying and selling in ATTO over the last 12 months; the most active is GOLDMAN SACHS GROUP INC with $13M.

Embed this chart
<iframe src="https://spotthemoney.com/embed/stocks/atto/" width="640" height="360" loading="lazy" style="border:0;max-width:100%" title="Who is trading ATTO — Spot the Money"></iframe>
<p>Source: <a href="https://spotthemoney.com/stocks/atto/">Spot the Money</a></p>

Prices insiders traded at

What price did insiders buy and sell at? Each marker is one open-market trade at the share price reported on its Form 4.

▲ Bought▼ SoldAverage reported price that day
$15$20$25Aug 2026Sep 2026
$15$20$25Aug 2026Sep 2026

Insiders reported 52 open-market trades in ATTO since Aug 5, 2026, at prices from $17.00 to $22.19; the most recent was a purchase at $17.00 on Aug 6, 2026. These are the prices on the filings, not adjusted for stock splits, and not a market price series.

Insiders trading ATTO

Everyone who filed a Form 4 for this ticker, by number of rows on record. "Bought" and "sold" count open-market purchases (code P) and sales only; awards, option exercises and shares withheld for tax are in the row count but not in those two columns.

InsiderRoleRowsBoughtSoldValue boughtValue soldLatest
GOLDMAN SACHS GROUP INCInsider29223$10.3M$2.3MAugust 6, 2026
WALSH COLINDirector29022—$644KAugust 6, 2026
Frazier Life Sciences XI, L.P.Insider910$10.0M—August 6, 2026
venBio Global Strategic Fund IV, L.P.Insider710$6.5M—August 6, 2026
Redmile Group, LLCInsider420$10.2M—August 6, 2026
SanofiInsider310$5.1M—August 6, 2026
Deep Track Biotechnology Master Fund, Ltd.Insider200——August 6, 2026
Attovia Therapeutics, Inc.President and CEO200——August 4, 2026
Chen HubertChief Medical Officer100——August 4, 2026
GOLD MITCHELLDirector100——August 4, 2026
Odrowaz ZanetaChief Business Officer100——August 4, 2026
Veiby PetterChief Scientific Officer100——August 4, 2026
You AngieDirector100——August 4, 2026
What kind of transactions these are 4 Form 4 codes
CodeMeaningRowsSharesValue at reported prices
SOpen-market sale46211,614$4.5M
CConversion of a derivative28168,986,302—
POpen-market purchase93,040,587$52.4M
AGrant or award71,152,300—

What each code means: Form 4 transaction codes.

Download CSV90 rows · 31 KB · insider and congressional rows for this ticker · all downloads

Insider transactions

FilerSideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
WALSH COLINExchange CAugust 6, 2026August 13, 20267d4,445,275——lateindirectderivativeForm 4 ↗
WALSH COLINExchange CAugust 6, 2026August 13, 20267d18,181,830——lateindirectderivativeForm 4 ↗
WALSH COLINOther PAugust 6, 2026August 13, 20267d500,000$17$8.5Mlateindirectalso in another filingForm 4 ↗
WALSH COLINExchange CAugust 6, 2026August 13, 20267d478,498——lateindirectForm 4 ↗
WALSH COLINExchange CAugust 6, 2026August 13, 20267d1,957,134——lateindirectForm 4 ↗
WALSH COLINOther SAugust 5, 2026August 13, 20268d76,418$21$1.6Mlateindirectalso in another filingForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d6,763$22$146KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d100$22$2,199lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d1,163$22$26KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d700$22$15KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d443$22$9,649lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d300$21$6,252lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d1,040$22$23KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d1,180$22$26KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d400$22$8,808lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d6,970$22$154KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d672$22$15KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d753$22$17KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d100$22$2,211lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d480$22$10KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d200$22$4,420lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d3,402$22$75KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d1,556$22$34KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d1,332$22$29KlateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d447$22$9,776lateindirectForm 4 ↗
WALSH COLINSell SAugust 5, 2026August 13, 20268d988$22$22KlateindirectForm 4 ↗
WALSH COLINOther PAugust 5, 2026August 13, 20268d85,000$21$1.8Mlateindirectalso in another filingForm 4 ↗
GOLDMAN SACHS GROUP INCExchange CAugust 6, 2026August 13, 20267d4,445,275——lateindirectderivativeForm 4 ↗
GOLDMAN SACHS GROUP INCExchange CAugust 6, 2026August 13, 20267d18,181,830——lateindirectderivativeForm 4 ↗
GOLDMAN SACHS GROUP INCBuy PAugust 6, 2026August 13, 20267d500,000$17$8.5MlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCExchange CAugust 6, 2026August 13, 20267d478,498——lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCExchange CAugust 6, 2026August 13, 20267d1,957,134——lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d76,418$21$1.6MlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d6,763$22$146KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d100$22$2,199lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d1,163$22$26KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d700$22$15KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d443$22$9,649lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d300$21$6,252lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d1,040$22$23KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d1,180$22$26KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d400$22$8,808lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d6,970$22$154KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d672$22$15KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d753$22$17KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d100$22$2,211lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d480$22$10KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d200$22$4,420lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d3,402$22$75KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d1,556$22$34KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d200$22$4,410lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d1,332$22$29KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d447$22$9,776lateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCSell SAugust 5, 2026August 13, 20268d988$22$22KlateindirectForm 4 ↗
GOLDMAN SACHS GROUP INCBuy PAugust 5, 2026August 13, 20268d85,000$21$1.8MlateindirectForm 4 ↗
Deep Track Biotechnology Master Fund, Ltd.Exchange CAugust 6, 2026August 10, 20264d18,181,818——derivativeForm 4 ↗
Deep Track Biotechnology Master Fund, Ltd.Exchange CAugust 6, 2026August 10, 20264d1,957,138——Form 4 ↗
venBio Global Strategic Fund IV, L.P.Exchange CAugust 6, 2026August 10, 20264d6,179,219——derivativeForm 4 ↗
venBio Global Strategic Fund IV, L.P.Exchange CAugust 6, 2026August 10, 20264d7,636,362——derivativeForm 4 ↗
venBio Global Strategic Fund IV, L.P.Exchange CAugust 6, 2026August 10, 20264d21,477,273——derivativeForm 4 ↗
venBio Global Strategic Fund IV, L.P.Buy PAugust 6, 2026August 10, 20264d382,352$17$6.5MForm 4 ↗
venBio Global Strategic Fund IV, L.P.Exchange CAugust 6, 2026August 10, 20264d665,147——Form 4 ↗
venBio Global Strategic Fund IV, L.P.Exchange CAugust 6, 2026August 10, 20264d821,998——Form 4 ↗
venBio Global Strategic Fund IV, L.P.Exchange CAugust 6, 2026August 10, 20264d2,311,870——Form 4 ↗
Redmile Group, LLCExchange CAugust 6, 2026August 7, 20261d782,854——indirectderivativeForm 4 ↗
Redmile Group, LLCBuy PAugust 6, 2026August 7, 20261d400,000$17$6.8MindirectForm 4 ↗
Redmile Group, LLCBuy PAugust 6, 2026August 7, 20261d200,000$17$3.4MForm 4 ↗
Redmile Group, LLCExchange CAugust 6, 2026August 7, 20261d782,854——indirectForm 4 ↗
SanofiExchange CAugust 6, 2026August 7, 20261d782,855——indirectderivativeForm 4 ↗
SanofiBuy PAugust 6, 2026August 7, 20261d300,000$17$5.1MindirectForm 4 ↗
SanofiExchange CAugust 6, 2026August 7, 20261d782,855——indirectForm 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d8,930,685——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d11,054,544——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d14,772,727——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d16,250,000——derivativeForm 4 ↗
Frazier Life Sciences XI, L.P.Buy PAugust 6, 2026August 6, 20260d588,235$17$10.0MForm 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d961,322——Form 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d1,189,940——Form 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d1,590,175——Form 4 ↗
Frazier Life Sciences XI, L.P.Exchange CAugust 6, 2026August 6, 20260d1,749,192——Form 4 ↗
You AngieOther AAugust 4, 2026August 6, 20262d27,000——derivativeForm 4 ↗
GOLD MITCHELLOther AAugust 4, 2026August 6, 20262d27,000——derivativeForm 4 ↗
Odrowaz ZanetaOther AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Veiby PetterOther AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Chen HubertOther AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Attovia Therapeutics, Inc.Other AAugust 4, 2026August 6, 20262d140,000——derivativeForm 4 ↗
Attovia Therapeutics, Inc.Other AAugust 4, 2026August 6, 20262d538,300——derivativeForm 4 ↗

Congressional trades

No member of Congress has disclosed a trade in this ticker in the filings we have parsed.

Tickers traded by the same people who traded ATTO, by number of filers in common. It shows overlap in public filings and nothing else.

  • REGN Regeneron Pharmaceuticals, Inc. - Common Stock 1 filer in common
  • LTGO Latigo Biotherapeutics, Inc. 1 filer in common
  • FULC Fulcrum Therapeutics, Inc. 1 filer in common
  • ICVX Icosavax, Inc. 1 filer in common
  • INZY Inozyme Pharma, Inc. 1 filer in common
  • TBIO Translate Bio, Inc. 1 filer in common

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 41490August 6, 2026August 13, 2026Form 4 list on EDGAR

Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.

Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.